ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
81 hedge funds and large institutions have $392M invested in Orchard Therapeutics plc American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
19% less capital invested
Capital invested by funds: $485M → $392M (-$92.6M)
Holders
81
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.92M | |
| 2 | +$5.11M | |
| 3 | +$4.05M | |
| 4 |
Morgan Stanley
New York
|
+$3.66M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.34M |
Top Sellers
| 1 | -$9.61M | |
| 2 | -$6.29M | |
| 3 | -$6.02M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$5.48M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$2.64M |